NOTHING ABOUT THIS REMDISIVIR MAKES ME THINK THEY SHOULD CONTINUE WITH THEIR RESEARCH ..........
“Elsewhere, California-based biotech company Gilead Sciences has released a new report on the potential benefits of the Remdesivir for coronavirus patients. In a study of 53 patients with severe cases given the drug as a last resort, 36 showed improvements. It was also observed of the 30 patients on ventilators before taking Remdesivir, 17 were able to be taken off the devices.
Among the remaining patients, eight worsened, seven died, and two showed no difference.”
“Among the remaining patients, eight worsened, seven died, and two showed no difference.”
—
That’s probably not much better than doing nothing. The drugs HCQ, zinc, and z-pac seem to work at least as well.